Alicia Kalogeropoulos receives AI-generated cancer vaccine after brain tumor recurrence
Updated
Updated · The Information · Apr 25
Alicia Kalogeropoulos receives AI-generated cancer vaccine after brain tumor recurrence
2 articles · Updated · The Information · Apr 25
Alicia, 35, received her second dose of the vaccine in the U.S. after purchasing nine doses from a clinic in Tijuana, Mexico, following surgery at Memorial Sloan Kettering Cancer Center.
Her husband Alex used multiple AI chatbots to devise a personalized treatment plan, aiming to avoid chemotherapy and radiation and preserve Alicia's immune system, despite high costs exceeding $250,000.
The case highlights a growing trend of citizen scientists leveraging AI for personalized cancer therapies, though experts caution about untested treatments and the challenges of scaling such individualized approaches.
Is using AI for your own cancer treatment a revolutionary act of patient empowerment?
Beyond chatbots, how is AI already transforming mainstream cancer research and care?
What happens when an AI's 'hallucination' becomes a patient's real-life treatment plan?
Could AI-driven medicine create a new health divide between the rich and everyone else?
How can we regulate AI medical advice without stifling life-saving innovation?
Vorasidenib Doubles Progression-Free Survival in IDH-Mutant Gliomas: A New Era of Targeted Therapy and AI-Driven Cancer Vaccines
Overview
In August 2024, the FDA approved vorasidenib, a targeted drug that inhibits the mutated IDH enzyme in low-grade gliomas, after the INDIGO trial showed it more than doubled progression-free survival and delayed the need for further treatment. Meanwhile, AI-driven personalized mRNA vaccines are emerging as a promising but experimental approach, using AI to identify tumor-specific neoantigens and innovative delivery systems to stimulate the immune system against brain tumors. Despite challenges like high costs, complex manufacturing, and the brain's immunosuppressive environment, combining vorasidenib's tumor control with AI vaccines' potential for long-term immune memory offers a hopeful future for brain cancer therapy.